Join our Newsletter
To receive News as it is released, please sign up.
June 7, 2021
Wound care AI company, focused on predictive analytics for faster treatment decisions to seek admission to AIM and raise funding through an IPO.
April 20, 2021
A company using technology for assessing wounds is getting more funding.
April 7, 2021
Spectral MD receives funding to further develop its artificial intelligence for wound healing assessment.
February 2, 2021
Spectral MD's DeepView imaging device collected data from 124 Adult and Pediatric Subjects to further develop its burn wound-healing prediction AI Algorithm
Spectral MD and RCSI to Advance Care for Chronic Wounds
December 17, 2020
Spectral MD and Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences Skin Wounds, and Trauma (SWaT) Research Center will collaborate to provide scientific oversight and assessment of the clinical value of Spectral MD's DeepView technology in chronic wounds
Spectral MD Initiates Multi-Center Clinical Study for Diabetic Foot Ulcer
December 17, 2020
Spectral MD's DeepView Wound Imaging System will collect critical data to further develop its multi-spectral imaging and artificial intelligence-based wound-healing prediction technology
Spectral MD Appoints Dr. Jeffrey Carter as Chief Medical Consultant and Wan Lung Eng as Chief Financial Officer
December 1, 2020
Spectral MD broadens the company's executive leadership team with the addition of two new members
Spectral MD and the American College of Cardiology to Advance Care for Critical Limb Ischemia
July 21, 2020
Spectral MD and the ACC will collaborate to provide scientific oversight and assessment of the clinical value of Spectral MD's DeepView technology to detect and assess critical limb ischemia
Spectral MD Names New CEO
June 29, 2020
Co-Founder Wensheng Fan, Spectral MD's Current COO, Promoted to CEO
Spectral MD and BARDA Agree to Start Enrollment in Clinics for Expanded Proof Of Concept Study (ePOC) Stage II Using the Company’s Improved DeepView SnapShot® Device
June 3, 2020
Spectral MD, Inc. (SMD) announced today that the Biomedical Advanced Research and Development Authority (BARDA) has agreed with SMD to proceed with Stage II enrollment for the ePOC after reviewing the performance of their next-generation imaging head in their Stage I ePOC study.
Spectral MD Welcomes Former Cleveland Clinic CEO Toby Cosgrove to the Spectral MD Board of Advisors
May 19, 2020
Toby Cosgrove joins the Spectral MD Board of Advisors and will assist all aspects of the Company's progression, including with burn and diabetic foot ulcer clinical trial and other strategic introductions.
New technology at UMC Burn Center
January 7, 2020
Fox 8 Live news talks to University Medical Center (UMC) Burn Center regarding burn wounds and how they are treated using DeepView®.
Credit: Fox 8 Local First
Modernizing wound care with Spectral MD, powered by Amazon SageMaker
August 15, 2019
Amazon Web Services (AWS) Machine Learning Blog
Spectral MD Receives Substantial Funding from BARDA for Continued Development of Spectral MD’s DeepView® Biomedical Imaging Device
July 23, 2019
Spectral MD receives $27 million under a 22-month contract, which can be extended for a total of up to $92 million
U.S. Invests In Burn Imaging Device For Mass Casualty Preparedness
July 19, 2019
CBRNE Central: Mass Casualty Preparedness Notable Contracts, Spectral MD
U.S. Department of Health and Human Services (HHS) sponsors development of portable, user-friendly burn imaging device
July 18, 2019
Program advances next-generation technology to improve care for burn patients.